How big is the ICD Market?
According to 6Wresearch internal database and industry insights, the Implantable Cardioverter Defibrillator (ICD) Market was valued at USD 7.1 Billion in 2024 and is projected to reach USD 10.6 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2025–2031.
The market is driven by the rising incidence of cardiovascular disorders, advancements in cardiac monitoring technology, and the growing aging population worldwide.
Key Growth Drivers of the ICD Market
- Rising global prevalence of arrhythmia and sudden cardiac arrest
- Increasing elderly population with chronic heart conditions
- Technological innovations in implantable cardiac devices
- Growing patient awareness and diagnosis rates of cardiac abnormalities
- Supportive healthcare reimbursement policies in developed regions
ICD Market Trends
The ICD market is seeing steady growth due to increasing acceptance of preventive cardiac care solutions. There is a rising shift toward subcutaneous ICDs (S-ICDs) as they reduce lead-related complications. Manufacturers are focusing on improving battery life, remote monitoring capabilities, and device miniaturization. Wearable defibrillator alternatives are emerging but ICDs remain the standard for long-term treatment. Integration with AI and cloud-based platforms for remote diagnostics is also influencing market demand.
Emerging Developments in the ICD Market
Developments in MRI-compatible ICDs are expanding eligibility for more patients. Research into leadless and wireless communication-enabled ICDs is also underway. Collaborations between tech and MedTech firms are resulting in smarter devices with improved data tracking and risk prediction. Growing investments in digital health are leading to remote monitoring and early detection tools integrated with ICD platforms. Clinical trials are ongoing to test combination devices that include pacing and defibrillation functions.
Major Companies in the ICD Market
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Micro Port Scientific Corporation
- Livan ova PLC
- Philips Healthcare
- ZOLL Medical Corporation
- Lepu Medical Technology
- Sorin Group
How big is the ICD Market : FAQ's
It was valued at USD 7.1 Billion in 2024 and is projected to reach USD 10.6 Billion by 2031.
The ICD market is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Increasing cardiac disease cases, technological advancements, and higher adoption in elderly patients.
Used for treating life-threatening arrhythmias and preventing sudden cardiac arrest in high-risk patients.
North America dominates due to advanced healthcare infrastructure and high awareness levels.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com